We give each case the time and attention it deserves, and we treat everyone who walks through our doors like family.
From auto accidents to defective product injuries to workers’ compensation claims, we’re here to help Louisiana injury victims.
We value building relationships with the many people and organizations that make Louisiana a great place to live.
Dudley DeBosier has a trusted team of personal injury lawyers who have been helping injured people in Louisiana.
Free Consultation
Doctors prescribe Belviq, also known as lorcaserin, to people who struggle with weight management. Unfortunately, Belviq has been linked to several types of cancer, and the Food and Drug Administration requested that Eisai Co., the drug’s manufacturer, remove Belviq and Belviq XR from the market.
Dudley DeBosier is now accepting inquiries from people who took Belviq and have been diagnosed with cancer. We believe that negligent drug manufacturers should be held responsible for the harm their products have caused.
If you or a loved one wants to discuss a Belviq lawsuit, contact the Louisiana drug injury attorneys at Dudley DeBosier today for a free consultation.
The FDA first approved Belviq (lorcaserin) in 2012. The drug was made available to consumers in 2013. The FDA continued clinical trials out of concern for cardiovascular health risks associated with the medication, but the trials revealed a link to cancer. Though several types of increased cancer risks have been linked to lorcaserin, the three most likely are pancreatic, colorectal, and lung cancers.
Federal regulators believe that the risks of taking Belviq outweigh the benefits. Though Eisai said they disagree with the FDA’s assertion, they’ve complied with FDA’s request to remove the drug from the market. Meanwhile, seven years passed between the drug’s release and the recall of lorcaserin due to cancer risks.
It’s tragic that a drug with links to cancer have been widely available for so long, but it’s a common story in our healthcare system. Users of Belviq deserve answers from Eisai, and the company should be held responsible for the costs now facing people who suffered dearly for trusting in this drug to help them manage their weight.
If you’ve taken Belviq and are concerned about your health, you should be aware of the signs of three types of cancer linked to this medication.
Pancreatic cancer often causes few to no symptoms early on. It’s only when it’s advanced that people experience:
If you are experiencing any signs of these cancers, see a doctor immediately. If Belviq contributed to your condition, you deserve compensation for the damages you’re experiencing.
If you’re considering taking legal action related to Belviq, contact the Louisiana drug injury lawyers at Dudley DeBosier to schedule a free consultation. We know how important these cases are for people who suffer needlessly because of a drug manufacturer’s negligence.
Contact our team today to schedule a free, no-obligation case assessment. We’re here to help.
